Trial Profile
A probe study of the safety, tolerability and immunogenicity of human immunodeficiency virus (HIV-1) gag DNA vaccine in healthy adults
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 02 Oct 2007
Price :
$35
*
At a glance
- Drugs V 520 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 02 Oct 2007 Status change
- 05 Dec 2005 New trial record.